<DOC>
	<DOCNO>NCT01086761</DOCNO>
	<brief_summary>The purpose study assess safety tolerability MP0112 ( novel , potentially long act VEGF inhibitor ) patient wet Age Related Macular Degeneration .</brief_summary>
	<brief_title>Study MP0112 Intravitreal Injection Patients With Wet Age Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Clinical sign angiographic evidence active primary progressive subfoveal choroidal neovascularisation ( CNV ) , include juxtafoveal lesion affect fovea FA study eye least 50 % total lesion area ETDRS bestcorrected visual acuity : 20/40 20/320 study eye 4 meter Male female age &gt; 50 year Written inform consent prior study procedure Willing , commit , able return ALL clinic visit complete studyrelated procedure . Prior treatment antiVEGF therapy study eye , include bevacizumab , ranibizumab , pegaptanib , well photodynamic therapy verteporfin Any prior concomitant therapy another investigational agent treat neovascular AMD study eye , except dietary supplement vitamin Subfoveal thermal laser therapy , externalbeam radiation therapy , transpupillary thermotherapy study eye Extrafoveal laser coagulation treatment within 12 week prior Baseline study eye Total lesion size &gt; 20mm2 ( include blood , scar neovascularization ) assess FA study eye Subretinal hemorrhage either 50 % total lesion area , blood fovea 2.54mm2 size study eye Scar fibrosis , make &gt; 50 % total lesion study eye Scar , fibrosis , atrophy involve center fovea Presence retinal pigment epithelial tear rip History vitreous hemorrhage within 4 week prior Visit 1 current hemorrhage study eye Presence cause CNV , include pathologic myopia ( spherical equivalent 8 diopter negative , axial length 25 mm ) , ocular histoplasmosis syndrome , angioid streak , choroidal rupture , multifocal choroiditis study eye History clinical evidence diabetic retinopathy , diabetic macular oedema vascular disease affect retina , AMD , either eye Prior vitrectomy study eye History retinal detachment treatment surgery retinal detachment study eye Ocular surgery ( include cataract removal ) study eye within 3 month enrolment Active intraocular inflammation ( grade trace ) study eye History allergy component study drug diagnostic device , fluorescein Advanced glaucoma intraocular pressure 22 mmHg study eye despite treatment Inability obtain fundus photograph fluorescein angiogram sufficient quality analyze graded central reading center History idiopathic autoimmuneassociated uveitis either eye Infectious conjunctivitis , keratitis , scleritis , endophthalmitis either eye Aphakia absence posterior capsule study eye Presence nonhealing wound , ulcer , fracture medical condition associate bleeding Use antimitotic antimetabolite therapy within 30 day 5 elimination halflives enrolment Premenopausal woman Any disorder condition contraindicates use investigational drug Participation another investigational drug study within 3 month enrolment Uncontrolled hypertension Previous stroke within 12 month study entry Systemic treatment antiVEGF drug Current treatment active systemic infection</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>